Anzeige
Mehr »
Login
Dienstag, 22.06.2021 Börsentäglich über 12.000 News von 662 internationalen Medien
Breaking News! Halo Collective: Kommt jetzt das NASDAQ-IPO?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CMEZ ISIN: CA1806341071 Ticker-Symbol: S6V 
Tradegate
17.06.21
18:12 Uhr
0,020 Euro
+0,002
+11,43 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
CLARITAS PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
CLARITAS PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0210,02422:00
0,0180,02722:00

Aktuelle News zur CLARITAS PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CLARITAS PHARMACEUTICALS Aktie jetzt für 0€ handeln
FrClaritas Pharmaceuticals Inc: Claritas Pharmaceuticals debenture private placement2
FrClaritas Pharmaceuticals Inc: Claritas receives shareholder OK for 1:20 rollback2
11.06.Claritas Pharmaceuticals Inc: Claritas arranges $183,750 private placement1
10.06.Claritas Pharmaceuticals Inc: Claritas receives shareholder support for consolidation1
10.06.Claritas Pharmaceuticals, Inc.: Claritas Announces Commitments from Company's Largest Shareholders to Vote for Approval of Share Consolidation1
07.06.Claritas Pharmaceuticals Inc: Claritas Pharmaceuticals shares for debt2
01.06.Claritas Pharmaceuticals Inc: Claritas Pharmaceuticals to settle debt with assets2
01.06.Claritas Pharmaceuticals, Inc.: Claritas Announces Transfer of GVHD Program and Cancellation of Related Debt as Company Focuses on Nitric Oxide Therapeutics1
28.05.Claritas Pharmaceuticals Inc: Claritas to settle $241,009 of debt with 6.88 M shares2
11.05.Claritas Pharmaceuticals Inc: Claritas CEO writes letter to shareholders6
11.05.Claritas Pharmaceuticals, Inc.: Claritas Pharmaceuticals Issues Letter to Shareholders2
29.04.Claritas Pharmaceuticals Inc: Claritas Pharmaceuticals arranges $250,000 financing6
22.04.Claritas and CMAX Clinical sign agreement for Phase 1 R-107 clinical study2
21.04.Claritas inks deal with CMAX Clinical Research for early-stage R-107 study1
21.04.Claritas Pharmaceuticals Inc: Claritas hires CMAX to complete R-107 study-
21.04.Claritas Pharmaceuticals, Inc.: Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107-
15.04.Claritas Pharmaceuticals Inc: Claritas Pharma 700,000 shares for debt-
14.04.Claritas Pharmaceuticals Inc: Claritas to acquire R-107 development licence6
14.04.Claritas Pharmaceuticals, Inc.: Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH5
13.04.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 13.04.2021237The following instruments on XETRA do have their first trading 13.04.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 13.04.2021 Aktien 1 US14167R2094 CareCloud Inc. 2...
► Artikel lesen
Seite:  Weiter >>
61 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3